Metallic zinc exhibits optimal biocompatibility for bioabsorbable endovascular stents.

Although corrosion resistant bare metal stents are considered generally effective, their permanent presence in a diseased artery is an increasingly recognized limitation due to the potential for long-term complications. We previously reported that metallic zinc exhibited an ideal biocorrosion rate within murine aortas, thus raising the possibility of zinc as a candidate base material for endovascular stenting applications. This study was undertaken to further assess the arterial biocompatibility of metallic zinc. Metallic zinc wires were punctured and advanced into the rat abdominal aorta lumen for up to 6.5months. This study demonstrated that metallic zinc did not provoke responses that often contribute to restenosis. Low cell densities and neointimal tissue thickness, along with tissue regeneration within the corroding implant, point to optimal biocompatibility of corroding zinc. Furthermore, the lack of progression in neointimal tissue thickness over 6.5months or the presence of smooth muscle cells near the zinc implant suggest that the products of zinc corrosion may suppress the activities of inflammatory and smooth muscle cells.

[1]  C. Mario,et al.  Biodegradable stents: the golden future of angioplasty? , 2015, The Lancet.

[2]  P. Serruys,et al.  A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial , 2015, The Lancet.

[3]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[4]  Raimund Erbel,et al.  Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial , 2013, The Lancet.

[5]  J. Tanigawa,et al.  Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. , 2007, European heart journal.

[6]  I. Barshack,et al.  Zinc reduces intimal hyperplasia in the rat carotid injury model. , 2004, Atherosclerosis.

[7]  P. Serruys,et al.  Bioresorbable scaffold technologies. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[8]  Jeremy Goldman,et al.  Zinc Exhibits Ideal Physiological Corrosion Behavior for Bioabsorbable Stents , 2013, Advanced materials.

[9]  P. Fitzgerald,et al.  Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable Polymer , 2004, Circulation.

[10]  A. Banning,et al.  Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention? , 2013, Heart.

[11]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[12]  A. Tomat,et al.  Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. , 2011, Nutrition.

[13]  A Haverich,et al.  Left main coronary artery fistula exiting into the right atrium , 2003, Heart.

[14]  Claude Roux,et al.  An evaluation of nanostructured zinc oxide as a fluorescent powder for fingerprint detection , 2008 .

[15]  J. Drelich,et al.  A new in vitro-in vivo correlation for bioabsorbable magnesium stents from mechanical behavior. , 2013, Materials science & engineering. C, Materials for biological applications.

[16]  J. Drelich,et al.  Tensile testing as a novel method for quantitatively evaluating bioabsorbable material degradation. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[17]  R. Virmani,et al.  Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent , 2001, Circulation.

[18]  H. Singer,et al.  First biodegradable metal stent in a child with congenital heart disease: Evaluation of macro and histopathology , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  Jeremy Goldman,et al.  A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[20]  Patrick W Serruys,et al.  Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? , 2011, Circulation.

[21]  S. Samman,et al.  Zinc and Regulation of Inflammatory Cytokines: Implications for Cardiometabolic Disease , 2012, Nutrients.

[22]  P. Tsao,et al.  Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. , 2004, Cardiovascular research.

[23]  R. Virmani,et al.  Angiographic and histological assessment of successfully treated late acute stent thrombosis secondary to a sirolimus-eluting stent. , 2007, European heart journal.

[24]  Bjoern Peters,et al.  The role of stents in the treatment of congenital heart disease: Current status and future perspectives , 2009, Annals of pediatric cardiology.

[25]  J. Drelich,et al.  Rates of in vivo (arterial) and in vitro biocorrosion for pure magnesium. , 2015, Journal of biomedical materials research. Part A.

[26]  H. Uehata,et al.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. , 2000, Circulation.

[27]  Antonio Colombo,et al.  Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in Humans , 2002, Circulation.

[28]  Soo-Jin Kang,et al.  In-stent neoatherosclerosis: a final common pathway of late stent failure. , 2012, Journal of the American College of Cardiology.

[29]  M. Centemero,et al.  Stent thrombosis: an overview , 2012, Expert review of cardiovascular therapy.

[30]  Young-Hak Kim,et al.  OCT-verified neoatherosclerosis in BMS restenosis at 10 years. , 2012, JACC. Cardiovascular imaging.

[31]  P. Acar,et al.  Stents in paediatric and adult congenital interventional cardiac catheterization. , 2014, Archives of cardiovascular diseases.

[32]  Daniel S. Levi,et al.  Materials and Manufacturing Technologies Available for Production of a Pediatric Bioabsorbable Stent , 2013, BioMed research international.

[33]  Frank Witte,et al.  In vitro and in vivo corrosion measurements of magnesium alloys. , 2006, Biomaterials.

[34]  Janine Fischer,et al.  Chemical surface alteration of biodegradable magnesium exposed to corrosion media. , 2011, Acta biomaterialia.

[35]  J. Drelich,et al.  Magnesium in the murine artery: probing the products of corrosion. , 2014, Acta biomaterialia.

[36]  Y. Hayashi,et al.  Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). , 2010, The American journal of cardiology.

[37]  Ericka Stricklin-Parker,et al.  Ann , 2005 .